Life sciences company spanning diagnostics, biopharma, and sequencing assays
Fapon operates across in-vitro diagnostics, biopharma manufacturing, and molecular assay development, with a tech stack anchored in RNA-seq, Python, Go, and workflow automation (Nextflow, Snakemake). The company is now adopting LangChain and vector databases (Qdrant), signaling a pivot toward AI-driven biomarker discovery and diagnostic intelligence — a shift that aligns with their stated pain point around automating biomarker discovery and scaling agent infrastructure.
Notable leadership hires: Business Development Director
Fapon is a global life sciences company headquartered in Dongguan, Guangdong, with 1,001–5,000 employees. Founded in 2001, the company serves diagnostics, biopharma, and biotherapy segments through integrated solutions including raw materials, reagents, and proprietary instrument platforms. Products reach 68 countries and regions, supporting over 2,500 business partners. Active development includes NGS assay pipelines, RNA-seq workflows for stool-based diagnostics, proprietary proteomics platforms, and lipid nanoparticle (LNP) drug formulations. The organization is research-heavy, with most open roles in senior R&D positions; limited hiring velocity suggests consolidation phase rather than rapid expansion.
Fapon uses RNA-seq, Python, Go, AWS, Git, R, Nextflow, and Snakemake for workflow automation and bioinformatics. Recently adopting LangChain and Qdrant to support AI-driven biomarker discovery.
Active pipelines include NGS assay development, stool-based human RNA-seq diagnostics, proprietary non-mass-spec proteomics workflows, and LNP-based drug product assays. Also advancing core chemistry solutions for sequencing technology and expanding IP portfolio.
Other companies in the same industry, closest in size